Literature DB >> 463912

Diagnosis and localization of pheochromocytoma. Detection by measurement of urinary norepinephrine excretion during sleep, plasma norepinephrine concentration and computerized axial tomography (CT-scan).

A Ganguly, D P Henry, H Y Yune, J H Pratt, C E Grim, J P Donohue, M H Weinberger.   

Abstract

The feasibility of differentiating patients with pheochromocytoma from other hypertensive patients by measuring urinary excretion rates of norepinephrine during sleep, a period of physiologic suppression of norepinephrine release, was investigated. The mean excretion rates of norepinephrine in 248 normal subjects and in 109 patients with essential hypertension were 1.03 +/- 0.03 and 1.12 +/- 0.06 (SEM) micrograms/hour, respectively, whereas the lowest excretion rate among the six patients with pheochromocytoma was about seven times higher. Plasma norepinephrine concentration in patients with pheochromocytoma was also consistently above the range observed in both normotensive and hypertensive subjects. CT scan correctly identified the same tumors visualized by selective arteriography. It is suggested that the usefulness of these approaches will provide simpler means of screening and detecting pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 463912     DOI: 10.1016/0002-9343(79)90064-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

Review 1.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

2.  The value of the clonidine-suppression test in the diagnosis of pheochromocytoma.

Authors:  B E Karlberg; L Hedman; S Lennquist; T Pollare
Journal:  World J Surg       Date:  1986-10       Impact factor: 3.352

3.  Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population.

Authors:  Keith L Brain; Jonathan Kay; Brian Shine
Journal:  Clin Chem       Date:  2006-09-21       Impact factor: 8.327

Review 4.  New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.

Authors:  Joakim Crona; David Taïeb; Karel Pacak
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

5.  Biochemical tests for pheochromocytoma: strategies in hypertensive patients.

Authors:  M J Young; C Dmuchowski; J W Wallis; G P Barnas; B Shapiro
Journal:  J Gen Intern Med       Date:  1989 Jul-Aug       Impact factor: 5.128

6.  Cost effectiveness in the detection of renal artery stenosis.

Authors:  W L England; C E Grim; M H Weinberger; S D Roberts
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

7.  [The influence of different diets and smoking on the clinical chemical diagnosis of pheochromocytoma, neuroblastoma, and carcinoid syndrome (author's transl)].

Authors:  G Heinemann; H Schievelbein; D Eberhagen; V Rahlfs
Journal:  Klin Wochenschr       Date:  1981-10-15

Review 8.  Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine.

Authors:  Svenja Nölting; Martin Ullrich; Jens Pietzsch; Christian G Ziegler; Graeme Eisenhofer; Ashley Grossman; Karel Pacak
Journal:  Cancers (Basel)       Date:  2019-10-08       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.